10/27/2015 - 10:05am

The authors say this is the first study to show that a pharmacist-based glucose control program can potentially improve outcomes for surgery patients, and also lead to lower costs. 

10/26/2015 - 12:32pm

The drug is the first to be approved specifically for unresectable or metastatic liposarcoma, the company said. 

10/23/2015 - 1:14pm

The drug uses SoluMatrix’s Fine Particle Technology to meet FDA guidelines that an NSAID contain the smallest possible dose over the shortest amount of time to prevent adverse drug events. 

10/22/2015 - 3:44pm

Merrimack Pharmaceuticals’ new pancreatic cancer drug was approved by the FDA Thursday. 

10/22/2015 - 10:55am

The new facility features 500,000 square feet of warehouse space and 12,700 square feet of office space, which is approximately 25 times larger than its original building on Sidney Street.

10/22/2015 - 10:04am

The Food and Drug Administration Thursday announced that it had approved Relypsa’s Veltassa (patiromer) for oral suspension.

10/21/2015 - 11:02am

“This crisis is taking lives — it’s destroying families and shattering communities all across the country,” President Obama said in remarks at a community forum meant to kick off his administration’s new push to curb opioid abuse. 

10/20/2015 - 12:20pm

The Food and Drug Administration has approved Tris Pharma’s pediatric amphetamine-based ADHD treatment.

10/20/2015 - 11:21am

The PADSP has also launched a website, DrugProtections.org, that explains the REMS program to patients and lists medication that are currently marketed with a REMS.